WAM
DALS

Wolverine Asset Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Wolverine Asset Management’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-108,999
Closed -$1.06M – 2492
2022
Q3 		$1.06M Buy
108,999
+107,999
+10,800% +$1.05M 0.01% 763
2022
Q2 		$9K Buy
+1,000
New +$9.73K ﹤0.01% 2020

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Wolverine Asset Management's DALS Position: Q4 2022 in Review

Wolverine Asset Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2022, closing a stake of 108,999 shares — an estimated $1.06M sold.

Wolverine Asset Management first reported a position in DALS in Q2 2022 and held it in 2 quarters. The position peaked at $1.06M in Q3 2022. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • Wolverine Asset Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 108,999 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $1.06M.
  • Wolverine Asset Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Wolverine Asset Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.06M in Q3 2022.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.